Organizations: Centre for Frontier AI Research (CFAR), Agency for Science, Technology and Research (A*STAR), Singapore 138632 · School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, China
Accurately ranking active ligands for a target protein pocket from massive chemical libraries remains a central challenge in virtual screening. DrugCLIP and its recent extensions substantially accelerate this process by encoding protein pockets and molecules into a shared embedding space. Despite this progress, further performance improvements typically require retraining the entire model, incurring substantial computational overhead and making target-specific customization inefficient. In this work, we formulate the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and propose PETA, a parameter-efficient framework that directly adapts pretrained model at test time. Given a target pocket, PETA constructs pocket-specific negatives through molecular diffusion and chemical validity filtering, and further moves them toward the reference ligand retrieved from structural databases via embedding-space mixup to create more challenging ranking tasks. A ranking objective then places greater emphasis on suppressing high-scoring invalid candidates that could contaminate the top-ranked screening results, providing structured supervision for lightweight adaptation. Experiments across diverse benchmarks demonstrate that this lightweight, pocket-specific adaptation outperforms both pretrained and fully retrained baselines while updating only the LayerNorm parameters, which account for approximately 0.03% of the full model.
Figures & tables
Figure 1: PETA enables effective and parameter-efficient adaptation for virtual screening.
Figure 2: Framework of PETA. (a) Given a target pocket, PETA retrieves a reference ligand from a matched holo complex, constructs pocket-aware negatives, and adapts only the LayerNorm parameters of the ligand encoder. (b) The adapted model is then used for virtual screening over the test molecular library.
Figure 3: Distributions of per-pocket average pocket–ligand cosine similarities on the DUD-E virtual screening benchmark.
Figure 4: Reference ligand and pocket-conditioned candidates for ABL1. The crystal structure PDB 2HZI represents an experimentally resolved binding conformation of ABL1 in complex with the reference ligand PD180970. The generated candidates exhibit structural similarity to the reference ligand, providing pocket-relevant samples for adaptation.
Method
AUROC
BEDROC
EF 0.5%
EF 1%
EF 5%
Vina
71.60
–
9.13
7.32
4.44
Glide-SP
76.70
40.70
19.39
16.18
7.23
RFscore
65.21
12.41
4.90
4.52
2.98
Pafnucy
63.11
16.50
4.24
3.86
3.76
OnionNet
59.71
8.62
2.84
2.84
2.20
PLANET
71.60
–
10.23
8.83
5.40
Table 1: Virtual screening results on DUD-E. The best results are highlighted in bold .
Method
AUROC
BEDROC
EF 0.5%
EF 1%
EF 5%
Surflex
51.47
–
–
2.50
–
Glide-SP
53.15
4.00
3.17
3.41
2.01
PLANET
57.31
–
4.64
3.87
2.43
GNINA
60.93
5.40
–
4.63
–
DeepDTA
56.27
2.53
–
1.47
–
BigBind
60.80
–
–
3.82
–
Table 2: Virtual screening results on LIT-PCBA. The best results are highlighted in bold .
Figure 5: Fine-grained ligand-ranking performance on the four-target FEP+ benchmark. Higher values indicate better performance.
rxu
Gxuinv-e
Gxuinv-h
Mixup
AUROC
BEDROC
EF 0.5%
EF 1%
EF 5%
×
✓
✓
✓
80.16
48.11
38.49
31.50
10.64
✓
×
×
✓
81.23
51.74
40.41
31.90
10.80
✓
×
✓
✓
81.48
51.59
40.05
32.52
10.89
✓
✓
×
✓
81.23
51.80
40.55
32.82
11.02
✓
✓
✓
×
81.32
51.29
41.12
33.18
11.35
✓
✓
✓
✓
82.62
53.86
42.34
34.65
11.44
Table 3: Ablation studies on DUD-E. The best results are highlighted in bold .
rxu
Gxuinv-e
Gxuinv-h
Mixup
AUROC
BEDROC
EF 0.5%
EF 1%
EF 5%
×
✓
✓
✓
55.60
7.15
8.07
5.32
2.29
✓
×
×
✓
57.66
7.51
9.08
6.62
2.86
✓
×
✓
✓
58.02
7.82
9.29
6.99
3.09
✓
✓
×
✓
59.44
7.69
9.17
6.53
3.06
✓
✓
✓
×
58.03
7.88
9.73
7.12
2.97
✓
✓
✓
✓
57.56
8.84
11.62
7.29
3.22
Table 4: Ablation studies on LIT-PCBA. The best results are highlighted in bold .
Figure 6: Ablation of α on virtual screening performance.